Literature DB >> 21679303

Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model.

Masaki Kimura1, Hui Yan, Zahid Rabbani, Takefumi Satoh, Shiro Baba, Fang-fang Yin, Thomas J Polascik, Craig F Donatucci, Zeljko Vujaskovic, Bridget F Koontz.   

Abstract

INTRODUCTION: The mechanisms of radiation-induced erectile dysfunction (ED) are unclear, as clinical studies are limited, and previous animal models were based on wide-field irradiation, which does not model current radiotherapy (RT) techniques. AIMS: To perform functional and morphological analyses of erectile function (EF) utilizing image-guided stereotactic prostate-confined RT in a rat model.
METHODS: Sixty young adult male rats aged 10-12 weeks old were divided into age-matched sham and RT groups. A single 20-Gy fraction to the prostate was delivered to RT animals. Penile bulb, shaft, and testes were excluded from treatment fields. MAIN OUTCOME MEASURES: Bioassay and intracavernous pressure (ICP) measurements were conducted at 2, 4, and 9 weeks following RT. Perfusion analysis of the corpora cavernosa (CC) was conducted using Hoechst injected prior to sacrifice. Penile shaft and cavernous nerve (CN) were evaluated by immunohistochemistry. Plasma testosterone level was analyzed using a testosterone enzyme-linked immunosorbent assay (ELISA) assay kit.
RESULTS: Irradiated animals demonstrated statistically significant time-dependent functional impairment of EF by bioassay and ICP measurement from 4 weeks. Neuronal nitric oxide synthase (NOS) expression was decreased in CN by 4 weeks. In CC, expression levels of anti-alpha smooth muscle actin and endothelial NOS were significantly decreased at 9 weeks. In penile dorsal vessels, smooth muscle/collagen ratio was significantly decreased at 4 and 9 weeks. Additionally, Hoechst perfusion showed time-dependent decrease in CC of RT animals, whereas CD31 expression was not affected. No toxicities were noted; testosterone levels were similar in both groups.
CONCLUSION: We demonstrated time-dependent ED following image-guided stereotactic RT. Our results imply that reduction of neuronal NOS expression in cavernous nerve could trigger consecutive reduction of smooth muscle content as well as blood perfusion in CC that resulted in corporal veno-occlusive dysfunction. Present study could be a cornerstone to future research that may bring comprehensive scientific understanding of radiation-induced ED.
© 2011 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21679303     DOI: 10.1111/j.1743-6109.2011.02351.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage.

Authors:  Istvan Kovanecz; Steve Rivera; Gaby Nolazco; Dolores Vernet; Denesse Segura; Sahir Gharib; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2012-09-13       Impact factor: 3.802

2.  Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction.

Authors:  Xuefeng Qiu; Jacqueline Villalta; Ludovic Ferretti; Thomas M Fandel; Maarten Albersen; Guiting Lin; Yutian Dai; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2012-04-30       Impact factor: 3.802

Review 3.  Animal models of erectile dysfunction.

Authors:  Snehlata V Gajbhiye; Kshitij S Jadhav; Padmaja A Marathe; Dattatray B Pawar
Journal:  Indian J Urol       Date:  2015 Jan-Mar

4.  A novel method to establish a rat ED model using internal iliac artery ligation combined with hyperlipidemia.

Authors:  Chao Hu; Feixiang Wang; Yehao Dong; Jican Dai
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

Review 5.  Radiation-induced erectile dysfunction: Recent advances and future directions.

Authors:  Javed Mahmood; Aksinija A Shamah; T Michael Creed; Radmila Pavlovic; Hotaka Matsui; Masaki Kimura; Jason Molitoris; Hem Shukla; Isabel Jackson; Zeljko Vujaskovic
Journal:  Adv Radiat Oncol       Date:  2016-06-03

6.  The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.

Authors:  Rebecca E Oberley-Deegan; Joshua J Steffan; Kyle O Rove; Kathryn M Pate; Michael W Weaver; Ivan Spasojevic; Barbara Frederick; David Raben; Randall B Meacham; James D Crapo; Hari K Koul
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.